Clinical Trial Update: A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study [Phase 2]

View source ↗

Summary

Phase II, single-center, single-arm clinical trial evaluating the safety and efficacy of golidocitinib in newly diagnosed peripheral T-cell lymphoma, with a cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Golidocitinib (golidocitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: RECRUITING